Debunking Gene Therapy: Safe, Affordable, and Closer Than You Think

​We're excited to welcome you to a special live webinar hosted by Rejuvenate Bio's co-founders, with a very special guest: Dr. Nicole Paulk, CEO and Founder of Siren Biotechnology.

​Gene therapy has a perception problem. Most people still think of it as experimental, dangerous, and decades away from being real. On March 10, Daniel Oliver (CEO) and Noah Davidsohn, PhD (CSO) are sitting down with one of the most respected AAV gene therapy scientists in the world to set the record straight.

​During the session we'll cover:

• ​Why gene therapy is safer than most people think, backed by real animal data

• ​How manufacturing breakthroughs are making it affordable at scale

• ​Why it's not just for rare diseases, and what that means for chronic and age-related conditions

• ​What three years of safety data from Rejuvenate Bio's dog trials actually shows

• ​The path from animal health to human clinical development

​We'll conclude with a live Q&A featuring Dr. Nicole Paulk, whose viral platforms are used across the industry and who has raised $28M from Founders Fund and Lux Capital to fight deadly brain cancers with AAV gene therapy. Getting unfiltered time with her is rare and we're thrilled to have her.

​We look forward to a candid, science-forward conversation and connecting with you live. In the meantime, you can review our investment offering and reserve your early bird terms at wefunder.com/rejuvenatebio.